Global Validation Regulations & Standards

Aseptic Process Validation Under FDA Stage 1–3: Media Fills, EM and Process Simulations

Aseptic Process Validation Under FDA Stage 1–3: Media Fills, EM and Process Simulations Aseptic process validation is a critical component of pharmaceutical manufacturing, particularly for sterile injectables. Regulatory agencies such as the FDA, EMA, and PIC/S have established clear guidelines to ensure that aseptic processes effectively mitigate microbiological contamination risks. This article delves into the various stages of aseptic process…

Continue Reading Aseptic Process Validation Under FDA Stage 1–3: Media Fills, EM and Process Simulations

Risk-Based Process Validation: Integrating QbD, ICH Q8–Q11 and FDA Lifecycle Guidance

Risk-Based Process Validation: Integrating QbD, ICH Q8–Q11 and FDA Lifecycle Guidance Risk-Based Process Validation: Integrating QbD, ICH Q8–Q11 and FDA Lifecycle Guidance Pharmaceutical validation is an essential aspect of ensuring that products are manufactured consistently to quality standards. The approach to validation has evolved significantly, driven largely by regulatory guidance and industry practices. A pivotal component in this evolution is…

Continue Reading Risk-Based Process Validation: Integrating QbD, ICH Q8–Q11 and FDA Lifecycle Guidance

Digital and Paperless Process Validation Systems for Managing Stage 1–3 Evidence

Digital and Paperless Process Validation Systems for Managing Stage 1–3 Evidence Introduction to Pharmaceutical Validation Pharmaceutical validation is a critical process that ensures products are consistently manufactured and controlled according to quality standards. As defined by regulatory authorities, validation is a documented process that provides a high degree of assurance that a specific process will consistently produce a product meeting…

Continue Reading Digital and Paperless Process Validation Systems for Managing Stage 1–3 Evidence

Digital and Paperless Process Validation Systems for Managing Stage 1–3 Evidence

Digital and Paperless Process Validation Systems for Managing Stage 1–3 Evidence Digital and Paperless Process Validation Systems for Managing Stage 1–3 Evidence In the evolving landscape of pharmaceutical manufacturing, the regulatory expectations for validation are becoming increasingly interconnected with technological advancements. Digital process validation represents a significant shift toward efficiency and compliance, particularly in light of guidance from regulatory bodies…

Continue Reading Digital and Paperless Process Validation Systems for Managing Stage 1–3 Evidence

Revalidation Triggers and Change Control in the Process Validation Lifecycle

Revalidation Triggers and Change Control in the Process Validation Lifecycle In the complex landscape of pharmaceutical manufacturing, adherence to regulatory guidelines is essential for ensuring product quality and patient safety. This article will delve into the critical aspects of process revalidation and the role of change control in maintaining compliance with regulatory expectations outlined by the US FDA, EMA, ICH…

Continue Reading Revalidation Triggers and Change Control in the Process Validation Lifecycle

Process Validation Documentation Package: What FDA, EMA and MHRA Expect to See

Process Validation Documentation Package: What FDA, EMA and MHRA Expect to See Process Validation Documentation Package: What FDA, EMA and MHRA Expect to See In the highly regulated pharmaceutical industry, process validation documentation is critical for demonstrating that manufacturing processes consistently produce products meeting quality standards. The guidelines from regulatory authorities such as the FDA, EMA, and MHRA provide a…

Continue Reading Process Validation Documentation Package: What FDA, EMA and MHRA Expect to See

Process Validation Governance: RACI, Validation Boards and Quality Council Oversight

Process Validation Governance: RACI, Validation Boards and Quality Council Oversight Process Validation Governance: RACI, Validation Boards and Quality Council Oversight In the pharmaceutical industry, structured governance is essential to ensure compliance with regulatory expectations surrounding process validation. The principles delineated by the US FDA, EMA, ICH, and PIC/S highlight how organizations must navigate complex validation landscapes, balancing rigorous scientific inquiry…

Continue Reading Process Validation Governance: RACI, Validation Boards and Quality Council Oversight

Stage 3 CPV Metrics and Dashboards for QA and Senior Management Review

Stage 3 CPV Metrics and Dashboards for QA and Senior Management Review Continuous Process Verification (CPV) is a crucial component of the pharmaceutical validation lifecycle, particularly in Stage 3, where established processes are continually monitored and optimized. Quality Assurance (QA) and regulatory professionals must ensure that CPV metrics and Key Performance Indicator (KPI) dashboards are designed effectively, not only to…

Continue Reading Stage 3 CPV Metrics and Dashboards for QA and Senior Management Review

Inspection Readiness for Process Validation: Mock Audits, Storyboards and Evidence Rooms

Inspection Readiness for Process Validation: Mock Audits, Storyboards and Evidence Rooms Inspection Readiness for Process Validation: Mock Audits, Storyboards, and Evidence Rooms Preparing for regulatory inspections focused on process validation is a critical component for pharmaceutical manufacturers. With regulatory bodies such as the US FDA, EMA, and MHRA all emphasizing compliance with Good Manufacturing Practices (cGMP), organizations must ensure that…

Continue Reading Inspection Readiness for Process Validation: Mock Audits, Storyboards and Evidence Rooms

Aligning Process Validation with ICH Q12 and Post-Approval Change Management

Aligning Process Validation with ICH Q12 and Post-Approval Change Management In the realm of pharmaceutical development and manufacturing, validation is a vital process that ensures the quality, safety, and efficacy of pharmaceutical products. Regulatory frameworks set forth by organizations such as the US FDA, EMA, MHRA, and PIC/S outline stringent expectations for manufacturers. This article will explore these expectations, focusing…

Continue Reading Aligning Process Validation with ICH Q12 and Post-Approval Change Management